Most patients with MBC treated with systemic therapies have only temporary responses to treatment, but some patients continue in CR following initial treatment. These data show that a small percentage of patients achieve long-term remissions with standard chemotherapy regimens. Remission consolidation strategies are needed.
No takes yet. Share an insight, caveat, or question.
Greenberg et al. (1996) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: